EyePoint(FRA) PV3A

Market CapN/A

Since IPON/A

5 YearN/A

1 YearN/A

1 MonthN/A

N/A

EyePoint Financials at a Glance

Market Cap

N/A

Revenue (TTM)

$2.39

Net Income (TTM)

-$262.96

EPS (TTM)

N/A

P/E Ratio

N/A

Dividend

N/A

Beta (Volatility)

N/A

Dividend

N/A

Beta (Volatility)

N/A

Price

N/A

Volume

N/A

Open

N/A

Price

N/A

Volume

N/A

Open

N/A

Previous Close

N/A

Daily Range

N/A

52-Week Range

N/A

Estimated Earnings Date

N/A

Dividend

N/A

Beta (Volatility)

N/A

Price

N/A

Volume

N/A

Open

N/A

Previous Close

N/A

Daily Range

N/A

52-Week Range

N/A

Estimated Earnings Date

N/A

PV3A News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About EyePoint

EyePoint Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapeutics that treat eye disorders. It offers FDA-approved sustained-release treatments in ophthalmology under the DEXYCU, ILUVIEN, Verisome, Retisert, and Durasert brands. The company was founded in 1987 and is headquartered in Watertown, MA.

Industry

Pharmaceuticals

Sector

Health Care

Employees

214

CEO

Jay S. Duker, MD

Website

www.eyepoint.bio

PV3A Financials

Key Financial Metrics (TTM)

Gross Margin

N/A

Operating Margin

N/A

Net Income Margin

N/A

Return on Equity

N/A

Return on Capital

N/A

Return on Assets

N/A

Earnings Yield

N/A

Payout Ratio

N/A

Stock Overview

Market Cap

N/A

Shares Outstanding

N/A

Volume

N/A

Avg. Volume

N/A

Financials (TTM)

Gross Profit

N/A

Operating Income

N/A

EBITDA

N/A

Operating Cash Flow

N/A

Capital Expenditure

N/A

Free Cash Flow

N/A

Cash & ST Invst.

N/A

Total Debt

N/A

EyePoint Performance Analysis

EyePoint annual revenue and year-over-year revenue growth by fiscal year
Fiscal year	Period end	Revenue	YoY growth
2022	2022-12-31	USD 39,395,825	26.1%
2023	2023-12-31	USD 42,565,291	8.0%
2024	2024-12-31	USD 40,004,964	-6.0%
2025	2025-12-31	USD 27,796,928	-30.5%

EyePoint annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal year	Period end	Diluted EPS	YoY growth
2022	2022-12-31	USD -2.61	51.7%
2023	2023-12-31	USD -1.68	-35.4%
2024	2024-12-31	USD -2.15	27.7%
2025	2025-12-31	USD -2.81	30.6%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q2 2026YOY CHG

Revenue

$0.44

+0.1%

Gross Profit

-$0.16

-0.0%

Gross Margin

-36.09%

-0.4%

Market Cap

N/A

Market Cap/Employee

$4.74

N/A

Employees

214

N/A

Net Income

-$81.25

+1.5%

EBITDA

-$83.16

+1.5%

Quarterly Fundamentals

Name

Q2 2026YOY CHG

Total Cash

$116.18

+46.7%

Total Debt

$19.56

+1.1%

Accounts Receivable

$0.08

+0.1%

Inventory

$1.65

+0.7%

Long Term Debt

$17.33

+0.9%

Short Term Debt

$2.23

N/A

Return on Assets

-115.30%

+2.0%

Return on Invested Capital

-47.91%

+1.0%

Free Cash Flow

-$55.09

+1.0%

Operating Cash Flow

-$54.05

+1.0%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

^GSPCS&P 500

^GSPCS&P 500$7,684.24-0.00%

^DJIDJI

^DJIDJI$53,254.61-0.01%

^IXICNASDAQ

^IXICNASDAQ$26,319.55-0.00%

BTCBitcoin

BTCBitcoin$78,890.00-0.00%

SPCXSPCX

SPCXSPCX$142.81+0.01%

AAPLAAPL

AAPLAAPL$315.25-0.01%

AMZNAMZN

AMZNAMZN$258.45-0.03%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

NVDANvidia

NVDANvidia$219.51-0.01%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF$9.53-0.04%

BIAFbioAffinity Technologies

BIAFbioAffinity Technologies$6.91+0.52%

INTCIntel

INTCIntel$89.07-0.00%

SOXLDirexion Shares ETF Trust - Direxion Daily Semiconductor Bull 3x ETF

SOXLDirexion Shares ETF Trust - Direxion Daily Semiconductor Bull 3x ETF$107.25-0.05%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$70.19-0.02%

NOKNokia

NOKNokia$9.88-0.03%

Questions About PV3A

What is the current price of EyePoint?

EyePoint is trading at N/A per share.

What is the 52-week range for EyePoint?

Over the past 52 weeks, EyePoint has traded between N/A and N/A.

How much debt does EyePoint have?

As of the most recent reporting period, EyePoint reported total debt of $19.56M.

How much cash does EyePoint have on hand?

EyePoint reported $96.61M in cash and cash equivalents in its most recent financial results.

What is EyePoint’s dividend yield?

EyePoint does not currently have a dividend yield.

EyePoint(FRA) PV3A

EyePoint Financials at a Glance

PV3A News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About EyePoint

PV3A Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

EyePoint Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About PV3A

What is the current price of EyePoint?

What is the 52-week range for EyePoint?

How much debt does EyePoint have?

How much cash does EyePoint have on hand?

What is EyePoint’s dividend yield?

Premium Investing Services